IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Abingworth LLP

Q3 2016 Holdings

Filed 2016-11-14 | 20 holdings | $4.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cellectis(CLLS)SPONDS ADR15117K103$2.4M100,00056.4%
Adaptimmune(ADAPY)SPONDS ADR00653A107$1.8M250,00041.3%
SientraCommon82621J105$19.8K2,199,0120.5%
ProteonCommon74371L109$18.4K2,017,8720.4%
ParatekCommon699374302$16.9K1,301,4130.4%
CempraCommon15130J109$9.3K383,9350.2%
Chiasma(CHMA)Common16706W102$6.1K2,080,5950.1%
Dicerna(DRNAUSD)Common253031108$5.6K945,7570.1%
NovanCommon66988N106$4.0K200,0000.1%
InnocollSPONDS ADR45780Q103$3.2K555,5550.1%
Lombard MedicalCommonG55598109$3.2K3,473,4520.1%
Cymabay(CBAYUSD)Common23257D103$3.1K1,600,0000.1%
Dermira(DERMEUR)Common24983L104$2.4K70,0000.1%
Senseonics(SENS1GBP)Common81727U105$2.0K516,8820.0%
Aurinia PharmaCommon03674U201$1.5K512,0360.0%
Immune DesignCommon45252L103$1.5K197,3000.0%
Anthera(AUPH)Common05156V102$1.4K437,9940.0%
RegulusCommon75915K101$1.1K327,3500.0%
HistogenixCommon43358V109$543176,9040.0%
Oncogenex PharmaCommon68230A106$195396,1040.0%